Researchers have discovered a potential new explanation for how metastatic colorectal cancer can avoid being attacked by the immune system. The findings challenge a theory scientists have relied on for 30 years and could help guide future research into treatments that make cancer more vulnerable to the body’s natural defenses. They may also change the environment around a tumor to help protect themselves from the immune system.
How does colorectal cancer avoid the immune system?
Your immune system helps protect you from illness, including by recognizing and attacking abnormal cells. However, cancer cells can sometimes find ways to escape this defense, allowing tumors to grow and spread.
For years, scientists have studied two naturally occurring substances that help regulate cell growth and death: sphingosine-1-phosphate (S1P) and ceramide.
S1P is a fat-like molecule that helps control several processes in the body, including cell growth. Ceramides are another type of fat-like molecule that helps regulate how cells function and when they die.
About 30 years ago, scientists proposed that the balance between these two substances helped determine whether cancer cells survived or died. According to this theory, higher levels of S1P encouraged cancer growth, while higher levels of ceramide helped trigger cell death.
New research suggests that the story may be more complicated.
Rather than acting mainly inside cancer cells, the researchers found that increased S1P and decreased levels of certain ceramides can occur in the tumor microenvironment — the area around a tumor that includes nearby cells, blood vessels, immune cells, and other substances.
The researchers found that S1P may help create a protective barrier around the tumor that makes it harder for the immune system to attack cancer cells.
In simple terms, cancer may not only find ways to survive on its own. It may also change its surroundings to make it harder for the body’s defenses to fight back.
Why does this discovery matter for metastatic colorectal cancer?
Metastatic colorectal cancer (mCRC) is colorectal cancer that has spread beyond the colon or rectum to other parts of the body, such as the liver or lungs. Although treatments are available, metastatic colorectal cancer can be difficult to treat, and researchers are continuing to investigate why cancer sometimes survives despite treatment and the body’s immune defenses.
This study offers a new way to understand how tumors may protect themselves. If cancer can create an environment that blocks immune attacks, researchers may be able to develop treatments that disrupt that protection.
For example, future studies could investigate whether blocking S1P or changing the balance of these substances could help the immune system better recognize and attack cancer cells.
This could also be important for research into immunotherapy, which helps the immune system recognize or fight cancer. Some people with colorectal cancer benefit from immunotherapy, depending on the characteristics of their tumor, but these treatments do not work for everyone.
Understanding how tumors avoid immune attack could help scientists identify new ways to improve treatment or develop new combinations of therapies.
What does this mean for patients?
For people living with metastatic colorectal cancer, this research provides another piece of the puzzle in understanding how cancer survives and spreads. It highlights that the area surrounding a tumor may be just as important to study as the cancer cells themselves.
However, this discovery is still an early step toward potential new treatments. The findings don’t mean that a treatment targeting S1P or ceramides is currently available or that changing these substances has been shown to improve outcomes for patients. More research is needed to understand whether this approach could safely help people with metastatic colorectal cancer.
In the meantime, your treatment options depend on factors such as your cancer’s stage, overall health, and the specific characteristics of your tumor. Molecular testing can help your care team identify changes in your cancer that may guide treatment decisions, including whether certain targeted therapies or immunotherapies may be appropriate. Clinical trials may also offer access to treatments being studied.
As researchers learn more about how colorectal cancer escapes the immune system, discoveries like this may help shape future approaches to treatment. The goal is to turn a better understanding of cancer into more effective options for people living with metastatic disease.
Disclaimer: The information provided in this article is for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Outcomes4Me is not acting as your caregiver, and any suggestions or guidance offered should not replace the advice of your healthcare provider or qualified medical professional. Always seek the guidance of your physician or other qualified health provider with any questions you may have regarding a medical condition.
